ABEO: FDA Accepts BLA Re-Submission for Pz-cel PDUFA Date of April 29
On November 14, 2024, Abeona Therapeutics, Inc. (ABEO) announced financial results for the third quarter of 2024 and provided a business...
146 Views
ABEO: Type A Meeting with FDA Concluded BLA Submission on Track for 2H24
On August 12, 2024, Abeona Therapeutics, Inc. (ABEO) announced financial results for the second quarter of 2024 and provided a business...
176 Views
ABEO: BLA Resubmission in 2H24
On May 15, 2024, Abeona Therapeutics, Inc. (ABEO) announced financial results for the first quarter of 2024 and provided a business update. The...
218 Views
Abeona Therapeutics Inc (ABEO) - Thursday, Feb 15, 2024
Abeona is developing a cell therapy for the rare disease RDEB, with FDA review ongoing and a target action date of May 25th
162 Views
No more insights